The GLP is committed to full transparency. Download and review our 2019 Annual Report

Brain organoids ‘giving insight’ into origins of autism, epilepsy and schizophrenia

| | February 3, 2020
d
Image: Pașca Lab/Stanford University
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Knowing how the human brain develops is critical to understanding how things can go awry in neurodevelopmental disorders, from intellectual disability and epilepsy to schizophrenia and autism. But between the fact that researchers cannot poke around inside growing human brains and the inadequacies of animal models, scientists currently do not fully understand the process.

Enter the invention of brain “organoids”: cells grown in 3-D clusters in the lab and designed to mimic the composition of the organ’s tissue.

[Psychiatrist Sergiu] Paşca and his colleagues have now used organoid models of parts of the human forebrain—the seat of higher cognitive abilities such as complex thought, perception and voluntary movement—to peer into how gene activity drives brain development. “The work brings new understanding of how, as the brain is formed, distinct regulatory regions of the genome are used to execute specific tasks—for example, the generation of specific types of neurons,” says neuroscientist Paola Arlotta of Harvard University, who was not involved in the new study. The researchers used their findings to map genes associated with certain disorders to specific cell types at specific stages, giving insight into the origins of conditions such as autism and schizophrenia.

Related article:  Viewpoint: Produce is sugary, GMO 'poison'? Scientific American embraces long-debunked food safety tropes

Read the original post

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend